CA209-908-0011: Phase Ib/II Clinical Trial of Nivolumab Monotherapy and Nivolumab in Combination with Ipilimumab in Pediatric Subjects with High Grade Primary CNS Malignancies (CheckMate908: CHECKpoint pathway and nivolumab cli

  • Goldman, Stewart (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date8/21/17 → 8/31/50

Funding

  • Bristol-Myers Squibb Company